[1] Oh J, Lee CJ, Kim IC,et al.Association of morning hypertension subtype with vascular target organ damage and central hemodynamics[J]. J Am Heart Assoc,2017,6(2):5424. [2] Snyder JJ, Collins AJ.KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004[J]. Am J Nephrol, 2009,30(1):44-54. [3] 柳胜生,傅东波,毕安华,等. 团队管理群组模式在社区糖尿病管理中的效果分析[J]. 中国慢性病预防与控制,2009,12(17):630-632. [4] Girndt M.Diagnosis and treatment of chronic kidney disease[J]. Der Internist,2017,(1):1-14. [5] Textor SC. Renal arterial disease and hypertension[J]. Med Clin North Am, 2017,101(1):65-79. [6] 许德民, 陈志萍, 唐新梅. 2009 年克拉玛依市居民死因监测分析及期望寿命[J]. 实用预防医学,2010,12(17):2399-2401. [7] 何云,王敬丽,高俊岭,等.不同管理模式对高血压肾脏早期损害病人的影响[J].全科护理,2014,8(12):2113-2116. [8] Loney-Hutchinson LM,Jean-Louis G,Ogedegbe O,et al. Group visits in the management of diabetes and hypertension:effect on glycemic and blood pressure control[J]. Current Diabetes Reports,2009,9:238-242. [9] Mulè G, Castiglia A, Cusumano C,et al. Subclinical kidney damage in hypertensive patients: a renal window opened on the cardiovascular system. focus on microalbuminuria[J]. Adv Exp Med Biol, 2016,11(1):22-24. [10] Cabarkapa V, Ilinci B, Deri M,et al. Cystatin C, vascular biomarkers and measured glomerular filtration rate in patients with unresponsive hypertensive phenotype: a pilot study[J]. Ren Fail, 2017,39(1):203-210.
2018, Vol. 25 
